Fludeoxyglucose F18 Injection, Solution
Product Images NDC 24562-003
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fludeoxyglucose F18 (NDC 24562-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Biomedical Research Foundation Of Northwest Louisiana, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (30 mL Vial Label)
Fludeoxyglucose F 18 Injection USP is a sterile, non-pyrogenic diagnostic, for intravenous use only. It is contained in a multiple-dose vial and has a shelf life that expires 12 hours after End of Synthesis (EOS). It contains no-carrier added fludeoxyghucose F 18 and 4.5 mg of sodium chloride in phosphate buffer per mL and ethanol. The recommended storage temperature is 25°C (77°F) and the half-life is 109.8 minutes. The correct dosage should be calculated from the date and time of calibration. It is imperative not to use the injection if it has become cloudy or contains particulate matter. The radioactive material is manufactured for Biomedical Research Foundation of Northwest Louisiana in Shreveport, LA 71103.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.